South Korea Uterine Fibroid Treatment Device Market Size & Outlook

The uterine fibroid treatment device market in South Korea is expected to reach a projected revenue of US$ 120.4 million by 2027. A compound annual growth rate of 10.2% is expected of South Korea uterine fibroid treatment device market from 2021 to 2027.
Revenue, 2020 (US$M)
$61.0
Forecast, 2027 (US$M)
$120.4
CAGR, 2021 - 2027
10.2%
Report Coverage
South Korea

South Korea uterine fibroid treatment device market, 2016-2027 (US$M)

South

South Korea uterine fibroid treatment device market highlights

  • The South Korea uterine fibroid treatment device market generated a revenue of USD 61.0 million in 2020 and is expected to reach USD 120.4 million by 2027.
  • The South Korea market is expected to grow at a CAGR of 10.2% from 2021 to 2027.
  • In terms of segment, surgical technologies was the largest revenue generating technology in 2020.
  • Ablation Techniques is the most lucrative technology segment registering the fastest growth during the forecast period.


Uterine fibroid treatment device market data book summary

Market revenue in 2020USD 61.0 million
Market revenue in 2027USD 120.4 million
Growth rate10.2% (CAGR from 2020 to 2027)
Largest segmentSurgical technologies
Fastest growing segmentAblation Techniques
Historical data2016 - 2019
Base year2020
Forecast period2021 - 2027
Quantitative unitsRevenue in USD million
Market segmentationSurgical Technologies, Ablation Techniques, Laparoscopic Techniques, Embolization Techniques
Key market players worldwideMedtronic PLC, Boston Scientific Corp, Stryker Corp, CooperSurgical, Hologic Inc, Lumenis, InSightec


Other key industry trends

  • In terms of revenue, South Korea accounted for 1.2% of the global uterine fibroid treatment device market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
  • In Asia Pacific, China uterine fibroid treatment device market is projected to lead the regional market in terms of revenue in 2027.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 242.5 million by 2027.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Uterine Fibroid Treatment Device Market Companies

Name Profile # Employees HQ Website

South Korea uterine fibroid treatment device market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to uterine fibroid treatment device market will help companies and investors design strategic landscapes.


Surgical technologies was the largest segment with a revenue share of 39.67% in 2020. Horizon Databook has segmented the South Korea uterine fibroid treatment device market based on surgical technologies, ablation techniques, laparoscopic techniques, embolization techniques covering the revenue growth of each sub-segment from 2016 to 2027.


Reasons to subscribe to South Korea uterine fibroid treatment device market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea uterine fibroid treatment device market databook

  • Our clientele includes a mix of uterine fibroid treatment device market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea uterine fibroid treatment device market, including forecasts for subscribers. This country databook contains high-level insights into South Korea uterine fibroid treatment device market from 2016 to 2027, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea uterine fibroid treatment device market size, by technology, 2016-2027 (US$M)

South Korea Uterine Fibroid Treatment Device Market Share, 2020 & 2027 (US$M)

South Korea uterine fibroid treatment device market size, by technology, 2016-2027 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more